Arcturus Therapeutics: Q3 Earnings Insights

Arcturus Therapeutics (NASDAQ:ARCT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Arcturus Therapeutics beat estimated earnings by 63.91%, reporting an EPS of $-0.61 versus an estimate of $-1.69.

Revenue was up $31.77 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $1.77 which was followed by a 19.22% drop in the share price the next day.

Here's a look at Arcturus Therapeutics's past performance:

To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.